-+ 0.00%
-+ 0.00%
-+ 0.00%

Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40

PUBT·08/05/2026 22:11:05
Listen to the news
Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon disposes of 1,540 common shares worth $175,806.40
  • Corcept Therapeutics Chief Accounting & Technology Officer Joseph Douglas Lyon sold 1,540 common shares on Aug. 3, 2026.
  • Shares were sold at $114.16, leaving him with 5,495 shares beneficially owned.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corcept Therapeutics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-335605), on August 05, 2026, and is solely responsible for the information contained therein.